Avotermin

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameAvotermin
Drug Alias Name阿伏特明avoterminaavotermineavoterminumJuvista +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionTransforming growth factor beta receptor 2 stimulants
TargetsTransforming growth factor beta receptor 2
Therapy Area/IndicationsWounds and InjuriesCicatrixKeloid +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesPoland +[12] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRenovo
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRenovo
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesCicatrixKeloid +[5] 

Other Information

ATC CodeN/A
Related LinksN/A